Loading clinical trials...
Loading clinical trials...
Prospective Observational Single Arm Open-Label Multicenter Study to Assess the Safety, Tolerability and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Adult Women
Conditions
Interventions
ellaOne® (ulipristal acetate)
ellaOne® (ulipristal acetate)
Locations
6
United States
PPRM Central clinic
Denver, Colorado, United States
PPRM Southwest clinic
Lakewood, Colorado, United States
Elizabeth Blackwell Health Center
Philadelphia, Pennsylvania, United States
Locust Health Center
Philadelphia, Pennsylvania, United States
Dept of Women & Child Health - Karolinska University Hospital
Stockholm, Sweden
Brook clinic
Belfast, United Kingdom
Start Date
May 1, 2010
Primary Completion Date
January 1, 2013
Completion Date
February 1, 2013
Last Updated
May 15, 2013
NCT06345586
NCT07115849
NCT06672016
NCT07365904
NCT07320651
NCT06334315
Lead Sponsor
HRA Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions